Contrast-enhanced Ultrasound Assessment of Treatment Response in a Patient with Multifocal Hepatocellular Carcinoma Treated with Transarterial Chemo and Radioembolization

Minimally invasive locoregional therapies have become important treatment options for patients with intermediate or late-stage hepatocellular carcinoma (HCC) who are ineligible for surgical resection or liver transplantation. Imaging modalities are essential for procedural guidance and for assessing...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Esika Savsani, Mohamed Tantawi, MD, Corinne E. Wessner, MBA, RDMS, RVT, Philip Lee, MD, Andrej Lyshchik, MD, PhD, Kevin Anton, MD, PhD, Colette M. Shaw, MD, Ji-Bin Liu, MD, John R. Eisenbrey, PhD
Formato:	article
Lenguaje:	EN
Publicado:	Editorial Office of Advanced Ultrasound in Diagnosis and Therapy 2021
Materias:	\|contrast-enhanced ultrasound\|hepatocellular carcinoma\|transarterial radioembolization\|transarterial chemoembolization\|treatment response Medical technology R855-855.5 Medicine R
Acceso en línea:	https://doaj.org/article/1eb063ed83bc4dde8db81afc1a651394
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Contrast-enhanced Ultrasound Assessment of Treatment Response in a Patient with Multifocal Hepatocellular Carcinoma Treated with Transarterial Chemo and Radioembolization

Ejemplares similares